Pseudocholinesterase levels in patients under electroconvulsive therapy

References

1. ↵
   1. Ding Z,
   2. White PF

   (2002) Anesthesia for electroconvulsive therapy. Anesth Analg 94:1351–1364.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Goodall R

   (2004) Cholinesterase heterogeneity: pharmacogenetic models and clinical implications. Current Anaesthesia &Critical Care 15:29–35.

   OpenUrl
3. ↵
   1. Soliday FK,
   2. Conley YP,
   3. Henker R

   (2010) Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. AANA J 78:313–320.

   OpenUrlPubMed
4. ↵
   1. Hernández AF,
   2. Gonzalvo MC,
   3. Gil F,
   4. Rodrigo L,
   5. Villanueva E,
   6. Pla A

   (1999) Distribution profiles of paraoxonase and cholinesterase phenotypes in a Spanish population. Chem Biol Interact 120:201–209.

   OpenUrl
5. ↵
   1. Abou-Hatab K,
   2. O'Mahony MS,
   3. Patel S,
   4. Woodhouse K

   (2001) Relationship between age and plasma esterases. Age Ageing 30:41–45.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Mathew RJ,
   2. Ho BT,
   3. Khan MM,
   4. Perales C,
   5. Wienman ML,
   6. Claghorn JL

   (1982) True and pseudo cholinesterases in depression. Am J Psychiatry 139:125–127.

   OpenUrlPubMed
7. 1. Mathew RJ,
   2. Hsu LL,
   3. Semchuk KM,
   4. Claghorn JL

   (1980) Acetylcholinesterase and pseudocholinesterase activities in anxiety. Am J Psychiatry 137:1118–1120.

   OpenUrlPubMed
8. ↵
   1. Aizenberg D,
   2. Hermesh H,
   3. Karp L,
   4. Munitz H

   (1989) Pseudocholinesterase in obsessive-compulsive patients. Psychiatry Res 27:65–69.

   OpenUrlPubMed
9. ↵
   1. Özer Y,
   2. Altunkaya H,
   3. Açıkgöz Ş,
   4. Demirel CB,
   5. Ayoğlu H,
   6. Özkoçak I

   (2005) The effects of gender and ageing on plasma pseudocholinesterase activity in a surgical population. Anestezi Dergisi 13:243–246.

   OpenUrl
10. ↵
    1. Modai I,
    2. Schwartz B,
    3. Aizenberg D

    (1987) Serum pseudocholinesterase in psychiatric patients. Biol Psychiatry 22:1238–1242.

    OpenUrlPubMed
11. ↵
    1. Thakar JH,
    2. Lapierre YD,
    3. Waters BG

    (1985) Cholinesterases in primary affective disorders. Clin Biochem 18:308–310.

    OpenUrlPubMed
12. ↵
    1. Puche E,
    2. García de la Serrana H,
    3. Mota C

    (1990) Effects induced by phenobarbital and phenytoin on the activity of pseudocholinesterase in serum and liver in the mouse. Pharmacol Toxicol 67:91–92.

    OpenUrlPubMed
13. ↵
    1. Berry M,
    2. Whittaker M

    (1975) İncidence of suxamethonium apnoea in patients undergoing ECT. Br J Anaesth 47:1195–1197.

    OpenUrlCrossRefPubMed
14. ↵
    1. Mirzakhani H,
    2. Welch CA,
    3. Eikermann M,
    4. Nozarı A

    (2012) Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand 56:3–16.

    OpenUrlPubMed
15. ↵
    1. Hoshi H,
    2. Kadoi Y,
    3. Kamiyama J,
    4. Nishida A,
    5. Saito H,
    6. Taguchi M,
    7. et al.

    (2011) Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. J Anesth 25:286–290.

    OpenUrlCrossRefPubMed